The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1 study to evaluate the safety and tolerability of the CD40 agonistic monoclonal antibody APX005M in subjects with solid tumors.
 
Johanna C. Bendell
No Relationships to Disclose
 
Marwan Fakih
Research Funding - Apexigen (Inst)
 
Jeffrey R. Infante
Research Funding - Apexigen (Inst)
 
David Lawrence Bajor
No Relationships to Disclose
 
Mihaela C. Cristea
Honoraria - Boehringer Ingelheim
Consulting or Advisory Role - Boehringer Ingelheim
Research Funding - Trovagene
 
Thomas Tremblay
Employment - Apexigen; KaloBios; Onyx
Stock and Other Ownership Interests - Apexigen
 
Ovidiu C. Trifan
Employment - Apexigen; Onyx
Stock and Other Ownership Interests - Apexigen
 
Robert H. Vonderheide
Consulting or Advisory Role - Apexigen; Clovis Oncology; Janssen; Lilly; MedImmune; Merck
Research Funding - Pfizer (Inst); Roche (Inst)